935 related articles for article (PubMed ID: 2566117)
1. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
2. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
3. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Heinrich G
N Engl J Med; 1989 Oct; 321(17):1197. PubMed ID: 2571933
[No Abstract] [Full Text] [Related]
4. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
Joachim CL; Mori H; Selkoe DJ
Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
[TBL] [Abstract][Full Text] [Related]
5. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
[TBL] [Abstract][Full Text] [Related]
6. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.
Tanzi RE; McClatchey AI; Lamperti ED; Villa-Komaroff L; Gusella JF; Neve RL
Nature; 1988 Feb; 331(6156):528-30. PubMed ID: 2893290
[TBL] [Abstract][Full Text] [Related]
7. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.
Kang J; Lemaire HG; Unterbeck A; Salbaum JM; Masters CL; Grzeschik KH; Multhaup G; Beyreuther K; Müller-Hill B
Nature; 1987 Feb 19-25; 325(6106):733-6. PubMed ID: 2881207
[TBL] [Abstract][Full Text] [Related]
8. [Alzheimer's disease and Down's syndrome. Some recent etiopathogenic data].
Golaz J; Charnay Y; Vallet P; Bouras C
Encephale; 1991; 17(1):29-31. PubMed ID: 1669030
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
10. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
[TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
[TBL] [Abstract][Full Text] [Related]
12. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
13. Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families.
Van Broeckhoven C; Genthe AM; Vandenberghe A; Horsthemke B; Backhovens H; Raeymaekers P; Van Hul W; Wehnert A; Gheuens J; Cras P
Nature; 1987 Sep 10-16; 329(6135):153-5. PubMed ID: 3306405
[TBL] [Abstract][Full Text] [Related]
14. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
[TBL] [Abstract][Full Text] [Related]
15. Down's syndrome and Alzheimer's dementia: defining an association.
Heston LL
Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome.
Matsubara E; Ghiso J; Frangione B; Amari M; Tomidokoro Y; Ikeda Y; Harigaya Y; Okamoto K; Shoji M
Ann Neurol; 1999 Apr; 45(4):537-41. PubMed ID: 10211483
[TBL] [Abstract][Full Text] [Related]
17. Physiological and pathological interrelationships of amyloid beta peptide and the amyloid precursor protein.
Larner AJ
Bioessays; 1995 Sep; 17(9):819-24. PubMed ID: 8763834
[TBL] [Abstract][Full Text] [Related]
18. Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar?
Davies CA; Mann DM
Am J Pathol; 1993 Dec; 143(6):1594-605. PubMed ID: 8256851
[TBL] [Abstract][Full Text] [Related]
19. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome.
Núñez E; Benito C; Tolón RM; Hillard CJ; Griffin WS; Romero J
Neuroscience; 2008 Jan; 151(1):104-10. PubMed ID: 18068305
[TBL] [Abstract][Full Text] [Related]
20. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]